Journal article · 2026 · Open access

Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response

Gauri Vijay Londhe, Swapnil Phade, Kishori Pankaj Khuspe

IP International Journal of Comprehensive and Advanced Pharmacology, 11(2), 71–81 · Published 8 August 2026 · DOI 10.18231/j.ijcaap.18440.1784180812

Open PDFView at the publisherCite this paper

In brief

“Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response” is a 2026 journal article by Gauri Vijay Londhe and 2 co-authors, published in IP International Journal of Comprehensive and Advanced Pharmacology. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY-NC-SA licence: the full text is free to read at IP International Journal of Comprehensive and Advanced Pharmacology.

Citations
0
References
63
Authors
3

Abstract

Variability between different people when responding to drugs is a very large problem in clinical therapeutics, and can lead to treatment failures, adverse drug reactions, or under-dosing. Pharmacogenetics involves the study of the variation of one gene which affects a person's response to a single drug, while pharmacogenomics focuses on multiple genes and genome-wide variation on drug efficacy, safety, absorption, distribution, metabolism and excretion. These disciplines collectively serve as the building blocks of precision medicine and will allow for tailoring of drug therapy based on a person's genetic make-up. This review aims to offer a broad overview of the genetic determinants of drug variability, especially polymorphisms in drug metabolizing enzymes, such as the cytochrome P450 (CYP450) family, drug transporters and therapeutic target receptors. Pharmacogenomic markers of relevance to clinical practice are covered in the fields of oncology, cardiovascular diseases, psychiatry and pain management, with examples of how these markers can be incorporated into evidence-based guidelines with the help of organizations like the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the U.S. Food and Drug Administration (FDA). The review also provides space for some of the emerging new approaches for high throughput genotyping, next generation sequencing, and bioinformatics, which have been driving the incorporation of pharmacogenomic information into clinical decision making. In addition, important factors that hinder routine clinical use of the test, such as economic issues, ethnic variation in allele frequency, ethical issues, data privacy, and the lack of health care professional training, are described and critically discussed. Future trends in the area of individualized therapy are discussed of emerging developments in pharmacometabolomics, microbiome research, artificial intelligence, predictive analytics and polygenetic risk scoring. In summary, this review provides a summary of the current understanding, highlights the existing gaps in the field, and highlights the increasing translational relevance of pharmacogenetics and pharmacogenomics to enhance therapeutic efficacy and progress personalized medicine.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Londhe, G. V., Phade, S., & Khuspe, K. P. (2026). Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response. IP International Journal of Comprehensive and Advanced Pharmacology, 11(2), 71–81. https://doi.org/10.18231/j.ijcaap.18440.1784180812

MLA 9

Londhe, Gauri Vijay, et al. “Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response.” IP International Journal of Comprehensive and Advanced Pharmacology, vol. 11, no. 2, 2026, pp. 71–81. https://doi.org/10.18231/j.ijcaap.18440.1784180812.

Chicago

Londhe, Gauri Vijay, Swapnil Phade, and Kishori Pankaj Khuspe. 2026. “Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response.” IP International Journal of Comprehensive and Advanced Pharmacology 11 (2): 71–81. https://doi.org/10.18231/j.ijcaap.18440.1784180812.

Harvard

Londhe, G. V., Phade, S. and Khuspe, K. P. (2026) ‘Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response’, IP International Journal of Comprehensive and Advanced Pharmacology, 11(2), pp. 71–81. doi:10.18231/j.ijcaap.18440.1784180812.

IEEE

G. V. Londhe, S. Phade, and K. P. Khuspe, “Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response,” IP International Journal of Comprehensive and Advanced Pharmacology, vol. 11, no. 2, pp. 71–81, 2026, doi: 10.18231/j.ijcaap.18440.1784180812.

BibTeX

@article{londhe2026pharmacogenomics,
  title     = {{Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response}},
  author    = {Londhe, Gauri Vijay and Phade, Swapnil and Khuspe, Kishori Pankaj},
  journal   = {IP International Journal of Comprehensive and Advanced Pharmacology},
  year      = {2026},
  volume    = {11},
  number    = {2},
  pages     = {71--81},
  doi       = {10.18231/j.ijcaap.18440.1784180812},
  url       = {https://doi.org/10.18231/j.ijcaap.18440.1784180812}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pharmacogenomics
  • pharmacogenetics
  • personalized medicine
  • genetic determinants of drug response
  • drug-metabolizing enzymes
  • cytochrome P450
  • drug transporters
  • clinical implementation

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Londhe, G. V., Phade, S., & Khuspe, K. P. (2026). Pharmacogenomics in personalized therapeutics: A comprehensive review of genetic determinants of drug response. IP International Journal of Comprehensive and Advanced Pharmacology, 11(2), 71–81. https://doi.org/10.18231/j.ijcaap.18440.1784180812

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at IP International Journal of Comprehensive and Advanced Pharmacology: sign in and open the PDF from this page.

Who wrote this paper?

Gauri Vijay Londhe, Swapnil Phade, Kishori Pankaj Khuspe.

What is the DOI of this paper?

10.18231/j.ijcaap.18440.1784180812, permanently at https://doi.org/10.18231/j.ijcaap.18440.1784180812. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.